OpGen Completes Growth Capital Financing
March 7, 2012
Gaithersburg, Md.— OpGen, Inc., a commercial stage whole-genome analysis company, announced today that it has reached agreement with new and existing investors to raise up to $17 million in a new growth capital financing. Harris & Harris Group, Inc. and Cross Creek Capital an affiliate of Wasatch Advisors, joined existing investors Highland Capital Partners, Versant [...]
Direct visualisation of cell organelle or sub-cellular structure in real time
March 7, 2012
AMSBIO has announced a new range of ready-to-use lentiviral particles that allow direct visualisation of organelles or structures in cells without manipulation. For real time visualisation, traditionally researchers have had to use plasmids for organelle markers, but the labelling was transitory. Now using the new AMSBIO lentiviral particles - researchers have an easy way to [...]
AB SCIEX Opens New Asia Pacific Application and Training Centre In Singapore’s Biomedical Hub
March 7, 2012
SINGAPORE-- AB SCIEX, a global leader in life science analytical technologies, today announced the opening of its newest Asia Pacific Application and Training Centre. Located in Singapore’s biomedical hub at Biopolis, this centre provides comprehensive service, support and application development to enable the scientific community in Singapore and the rest of ASEAN, Australia, New Zealand, [...]
Professor from Milan Awarded Inaugural Arnold O. Beckman Medal for Electrodriven Separations
March 7, 2012
BREA, CALIF. — Professor Pier Giorgio Righetti of the Polytechnic of Milano Department of Chemistry, Materials and Chemical Engineering was presented with the inaugural Arnold O. Beckman Award and Medal for Outstanding Achievements in the Field of Electrodriven Separations on Monday, February 13th during the 27th International Symposium on MicroScale Bioseparations and Analyses (MSB 2012) [...]
Pall Corporation Second Quarter Sales Increase 8%
March 7, 2012
PORT WASHINGTON, N.Y.,- Pall Corporation (NYSE:PLL) today reported financial results for the second quarter of fiscal year 2012 which ended on January 31, 2012. Second Quarter and Six Months Sales and Earnings Overview Second quarter sales were $698 million, an increase of 8.2% over last year. Sales in local currency ("LC") increased 8.0%. Orders in [...]
Illumina Introduces TruSeq® Amplicon – Cancer Panel for MiSeq® System
March 7, 2012
SAN DIEGO-- Illumina (NASDAQ:ILMN) today introduced the TruSeq Amplicon - Cancer Panel, a highly multiplexed panel that will allow researchers to accurately sequence hundreds of the most relevant cancer loci, even in difficult samples such as formalin-fixed, paraffin embedded (FFPE) tumor samples. With the ability to detect mutations below 5% frequency, the TruSeq Amplicon assay [...]
Transgenomic Reports Fiscal Year 2011 Financial Results
March 7, 2012
Omaha, Neb. - Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the year ended December 31, 2011 and provided a business update. “Transgenomic enjoyed a landmark year in 2011, with revenue growth quarter-over-quarter and year-over-year as well as an attention to expense management translating into positive modified EBITDA for both the fourth quarter and [...]
March 7, 2012
Chalfont St Giles, UK – GE Healthcare, a unit of GE (NYSE: GE) announced today it has reached an agreement to acquire Xcellerex, Inc. a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of [...]
March 7, 2012
Porvair Sciences has introduced a new range of high grade polypropylene flip cap centrifuge tubes that combine ease of use, chemical resistance and high speed tolerance. Designed for easy one-handed operation the secure leak proof flip cap lid on each centrifuge tube can also be unscrewed. Available in a range of standard sizes the dimensions [...]
Bio-Rad Introduces New Bio-Plex® Assays for Immunology and Cancer Biomarker Research
March 6, 2012
The Bio-Plex Pro Human Th17 Cytokine Panel and Bio-Plex Pro Human Cancer Biomarker Panel 1 deliver high-performance multiplex assays for immunology and cancer research, respectively. Hercules, CA - Bio-Rad Laboratories announced the launch of its new magnetic bead–based multiplex immunoassaysfor human T-helper type 17 (Th17) cytokines and cancer biomarkers. The Bio-Plex Pro™ immunoassays take advantage [...]

